未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trial信迪利单抗联合安罗替尼与序贯化疗治疗晚期三阴性乳腺癌(SPACE)的疗效与安全性:一项单臂、多中心II期研究的初步结果
Li, H.; Zhou, D.; Yv, Z.; Liao, Y.; Huang, J.; Sun, S.; Zheng, F.; Li, B.; Fang, S.; Qiang, L.; Ren, G.; Wang, X.; Baoxuan, Z.; Fan, B.; Zhao, X.; Li, W.; Wang, Z.; Fu, H.; Sun, X.; Shi, Z.
分享
收藏
分享
收藏
分享
收藏The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors
Zhao, Ruizhi; Shao, Han; Shi, Guiqing; Qiu, Yanyan; Tang, Tianlan; Lin, Yuping; Chen, Silin; Huang, Cheng; Liao, Siqin; Chen, Jinhua; Fu, Haiying; Liu, Jianzhi; Xu, Benhua; Liu, Tingbo; Zhang, Yujing; Yang, Yong
分享
收藏
分享
收藏A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myelomaXPO-1抑制剂的新型两步给药可能会增强抗BCMA car-t在复发/难治性髓外多发性骨髓瘤中的作用
Wang, Di; Fu, Haiying; Que, Yimei; Ruan, Haitao; Xu, Menglei; Long, Xiaolu; Yu, Qiuxia; Li, Chunhui; Li, Zhe; Cai, Songbai; Chen, Wei; Sun, Cong; Hu, Guang; Wang, Shuai; He, Donggou; Mei, Jianming; Wang, Wen; Li, Chunrui
分享
收藏
分享
收藏Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple-negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trial
Li, H.; Zhou, D.; Yv, Z.; Liao, Y.; Huang, J.; Sun, S.; Zheng, F.; Li, B.; Fang, S.; Qiang, L.; Ren, G.; Wang, X.; Zhang, B.; Fan, B.; Zhao, X.; Li, W.; Wang, Z.; Fu, H.; Sun, X.; Shi, Z.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏